A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients
Open Access
- 27 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (4) , 809-815
Abstract
The aim of this study was to prospectively evaluate the use of intraluminal ethanol for the prevention of catheter-associated bloodstream infection (CABSI) in immunosuppressed haematology patients. Patients receiving chemotherapy for haematological malignancy or haematopoietic cell transplantation were randomized in a double-blinded manner to receive either intraluminal 70% ethanol/water or heparinized saline locks on a daily basis throughout a prophylactic treatment period. The primary endpoint was an episode of CABSI (defined as ‘bacteraemia in a febrile patient with a central venous catheter that was in use within the preceding 48 h and with no other identified focus of infection’). The trial was registered with the Australian Clinical Trials Register: number ACTRN012605000383662. There were 34 and 30 prophylactic treatment periods in the ethanol and control groups, respectively. CABSI occurred in 3 (9%, 0.60/100 catheter-days) and 11 (37%, 3.11/100 catheter-days) prophylactic treatment periods in the ethanol and control groups, respectively (OR = 0.18, 95% CI 0.05–0.65, P = 0.008). Eleven (32%) and 5 (17%) patients in the ethanol and control groups, respectively, remained afebrile throughout the prophylactic treatment (P = 0.18). The daily administration of ethanol locks into lumens of central venous catheters effectively reduces the incidence of CABSI.Keywords
This publication has 33 references indexed in Scilit:
- Randomized Trial of Prevention of Catheter-Related Bloodstream Infection by Continuous Infusion of Low-Dose Unfractionated Heparin in Patients With Hematologic and Oncologic DiseaseJournal of Clinical Oncology, 2005
- Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trialJournal of Hospital Infection, 2005
- Prophylactic Urokinase in the Management of Long-Term Venous Access Devices in Children: A Children's Oncology Group StudyJournal of Clinical Oncology, 2004
- The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysisAmerican Journal of Infection Control, 2003
- Prolonged Antimicrobial Activity of a Catheter Containing Chlorhexidine-Silver Sulfadiazine Extends Protection against Catheter Infections In VivoAntimicrobial Agents and Chemotherapy, 2001
- Infusion Therapy Team and Dressing Changes of Central Venous CathetersInfection Control & Hospital Epidemiology, 1999
- A Clinical Trial on the Prevention of Catheter-Related Sepsis Using a New Hub ModelAnnals of Surgery, 1996
- The Incidence of First Hickman Catheter-Related Infection and Predictors of Catheter Removal in Cancer PatientsInfection Control & Hospital Epidemiology, 1995
- Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality1994
- Hub Colonization as the Initial Step in an Outbreak of Catheter‐Related Sepsis Due to Coagulase Negative Staphylococci during Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 1984